ClearBridge Investments
JAZZ icon

ClearBridge Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

ClearBridge Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-430
Closed -$61K – 1125
2016
Q2 		$61K Buy
+430
New +$63.4K ﹤0.01% 855
2016
Q1 		– Sell
-100
Closed -$14K – 1085
2015
Q4 		$14K Hold
100
– – ﹤0.01% 1005
2015
Q3 		$13K Hold
100
– – ﹤0.01% 1052
2015
Q2 		$18K Hold
100
– – ﹤0.01% 1032
2015
Q1 		$17K Buy
+100
New +$17.2K ﹤0.01% 1068

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ClearBridge Investments's JAZZ Position: Q3 2016 in Review

ClearBridge Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 430 shares — an estimated $61K sold.

ClearBridge Investments first reported a position in JAZZ in Q1 2015 and held it in 5 quarters. The position peaked at $61K in Q2 2016. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

  • ClearBridge Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • ClearBridge Investments sold 430 Jazz Pharmaceuticals shares in Q3 2016, an estimated $61K.
  • ClearBridge Investments first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 5 quarters.
  • ClearBridge Investments's Jazz Pharmaceuticals position peaked at $61K in Q2 2016.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on ClearBridge Investments's 13F filing for Q3 2016, filed 14 Nov 2016.